Taxol and taxanes from plants other than Taxus species

Home - State of art - Objective - Partners - References

State of art

Taxol® (generic name paclitaxel) is an effective antineoplastic agent employed for the treatment of a variety of cancers that constitute a significant percentage of total cases affecting our population such as ovarian, breast or lung cancer.
Taxol is a rare and highly functionalized diterpenoide plant compound originally extracted from the bark of Taxus brevifolia.
(read more here...)

Objective

We have recently showed that cell cultures obtained from plants different from Taxus are able to produce Taxol and taxanes.
This finding suggested that plants other than taxus possess enzymes involved in the biosynthesis of paclitaxel and related compounds, generally named taxanes.
(read more here...)

Partners

  • Department of Pharmaceutical Sciences, University of Genoa, Genoa, Italy (Mariangela Miele, Alessandro Balbi, Mauro Mazzei, Anna Maria Mumot)
  • National Institute for Cancer Research, Genoa, Italy (Paolo Degan, Laura Ottaggio, Camillo Rosano, Paolo Romano)
    (read more here...)

  • References

  • Wani MC, Taylor HL, Wall ME, Coggon P, McPhail AT. 1971, J Am Chem Soc 93: 2325-2327.
  • Nicolaou KC, Yang Z, Liu JJ, Ueno H, Nantermet PG, Guy RK, Claiborne CF, Renaud J, Couladouros EA, Paulvannan K, Sorensen EJ. Nature. 1994; 367: 630-634.
    (read more here...)

  •  
    This project is partially supported by Compagnia di San Paolo, Torino